Think-Find-Solve activities for insulin self-management in children with type 1 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This cluster-randomized trial will compare an insulin self-management activity book plus routine education against routine education alone in two Istanbul hospitals. Participants are children aged 8–12 with type 1 diabetes and their parents, with assessments at baseline, 1 month, and 3 months. One hospital will implement the intervention while the other serves as control, with an initial pilot phase to refine procedures. The study targets improving adherence to insulin therapy and self-management behaviors through an engaging, parent-involved educational tool. Ethical approval and institutional permissions are prerequisites before initiation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* For the child:

Diagnosed with Type 1 diabetes Aged between 8 and 12 years Able to read and write Able to understand and speak Turkish Diagnosed with diabetes for at least one year Regularly attending routine three-month outpatient clinic follow-ups Having no other diseases or medical conditions aside from diabetes The child agrees to participate in the study

-For the Parent: Being the mother or father of the child with Type 1 diabetes Being the primary caregiver responsible for the child Able to read and write Agrees to participate in the study

Exclusion Criteria:

The child uses an insulin pump

\-

Where it's running

• Marmara University
  Istanbul, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Fatma Toksöz Güneş, MsC, PhD Candidate
• Email: f.toksoz1996@gmail.com
• Phone: +905055232738

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Automated insulin therapy for young children with type 1 diabetes

  This study tests if a new automated insulin delivery system can improve the quality of life and blood sugar control for young children with type 1 diabetes compared to traditional methods.

  Recruiting Fondation Lenval · Nice, France · NCT06875167

• Semaglutide on body composition in adults with type 1 diabetes and overweight/obesity

  This study tests whether weekly semaglutide changes body composition in adults with type 1 diabetes who are overweight or obese, compared with a placebo over 24 weeks.

  Recruiting Phase 2/3 McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT07891156

• Next Generation Extended Wear Sensors in Type 1 and Type 2 Diabetes

  This study tests a new extended wear sensor and algorithm in people with type 1 or type 2 diabetes to see how well it works across adults and children.

  Recruiting at 11 sites Medtronic MiniMed, Inc. · Chula Vista, California and 17 other locations · NCT07864168

• CGM-guided carb awareness education for adults with Type 1 diabetes

  This study tests whether teaching mealtime insulin dosing using CGM data helps adults with Type 1 diabetes who don’t usually count carbs.

  Recruiting University of California, Los Angeles · Los Angeles, California · NCT07807280

• Safety and effectiveness of GLP-1 receptor agonists and SGLT inhibitors added to insulin in adults with type 1 diabetes

  This registry will see if adding GLP-1RA or SGLTi therapies to insulin helps adults with type 1 diabetes over one year.

  Recruiting at 17 sites Indiana University · Newport Beach, California and 16 other locations · NCT07676565

• Near-sensor insulin delivery with CGM in people with type 1 diabetes

  A small early-feasibility study tests a dual-port insulin patch pump that includes a CGM sensor to see if delivering insulin near the sensor affects glucose readings and whether an automated control algorithm can manage glucose.

  Recruiting Early Phase 1 ClinSurge Research · Toronto, Ontario · NCT07655076

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.